HOME Top Market Reports Topical Drug Delivery Market by Product Type (Formulation (Solid, Cream, Lotion, Paste, Liquid), Transdermal (Patch, Gel)), Route of Administration (Skin, Ophthalmic, Rectal, Vaginal, Nasal), & Facility of Use (Hospital, Clinic, Home care, Research) - Global Forecast to 2021

Topical Drug Delivery Market by Product Type (Formulation (Solid, Cream, Lotion, Paste, Liquid), Transdermal (Patch, Gel)), Route of Administration (Skin, Ophthalmic, Rectal, Vaginal, Nasal), & Facility of Use (Hospital, Clinic, Home care, Research) - Global Forecast to 2021

By: marketsandmarkets.com
Publishing Date: March 2017
Report Code: MD 5119

 

  Speak to Analyst Enquiry Before Buying Webinar
purchase report
download pdf  request for customisation


The topical drug delivery market is expected to reach USD 125.88 Billion by 2021 from USD 92.40 Billion in 2016 at a CAGR of 6.4% during the forecast period. Major factors driving the growth of this market are the high incidence of burn injuries, rising geriatric population, and increasing incidence of diabetes. However, the negative impact of product recalls may restrain the growth of this market in the coming years.

North America is expected to dominate the global market in 2016, with the U.S. accounting for a major share of this regional market. High incidence of skin diseases (such as psoriasis, eczema, and skin cancer), increasing inclination of patients towards pain-free drug delivery, launch of new topical products, and increasing focus of prominent players on strengthening their presence in the North American market (through acquisitions and expansions) are expected to drive the growth of this regional market.

Europe was the second-largest market for topical drugs in 2016. The European market is mainly driven by the increasing geriatric population, high incidence of skin cancer, increasing governmental initiatives for supporting medical innovation, and growth of the European healthcare sector. To leverage the growth opportunities in this regional market, various prominent players are focusing on strengthening their presence in Europe through acquisitions, expansions, and product launches and approvals. For instance, in February 2014, Galderma S.A. (Switzerland) received marketing authorization from the European Commission for its Mirvaso gel (indicated for the symptomatic treatment of facial erythema of rosacea in adults) in Europe.

The Asia-Pacific market is slated to grow at the highest CAGR during the forecast period. The high growth in the Asia-Pacific market can be attributed to the rising geriatric population, increasing healthcare expenditure, rising disposable income, and growing focus of global pharmaceutical companies on the markets in emerging APAC countries. China, India, and Japan are some of the major markets for topical drugs in the Asia-Pacific region.

The topical drug delivery market is a fragmented market with several global as well as local players operating in various market segments. The key players in this market are Galderma S.A. (Switzerland), GlaxoSmithKline plc. (U.K.), Valeant Pharmaceuticals International, Inc. (Canada), Crescita Therapeutics Inc. (Canada), Medpharm (U.K.), 3M (U.S.), Bayer AG (Germany), Novartis AG (Switzerland), Janssen Global Services, LLC (U.S.), and Cipla (India).

Target Audience:

  • Hospitals and Private Clinics
  • Ambulatory Surgery Centers (ASCs)
  • Academic Institutes
  • Medical Research Institutes
  • Market Research and Consulting Firms
  • Venture Capitalists
  • Suppliers and Distributors of Topical Products

To know about the assumptions considered for the study, download the pdf brochure

Scope of the Report

This report categorizes the global market into the following segments and subsegments:

Topical Drug Delivery Market, by Product Type

  • Formulation
    • Semi-solids
      • Ointments
      • Creams
      • Gels
      • Lotions
      • Pastes
    • Liquids
      • Suspension
      • Solutions
    • Solids
      • Powders
      • Suppositories
  • Devices (Transdermal Drug Delivery)
    • Patches
    • Gels

Topical Drug Delivery Market, by Route of Administration

  • Skin
  • Ophthalmic
  • Rectal
  • Vaginal
  • Nasal

Topical Drug Delivery Market, by Facility of Use

  • Hospitals and Private Clinics
  • Home Care Settings
  • Other Facilities of Use

Note: Others facilities of use include research institutes and diagnostic centers.

Topical Drug Delivery Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • RoE
  • Asia-Pacific
    • Japan
    • China
    • India
    • RoAPAC
  • Rest of the World (RoW)

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company‘s specific needs.

The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to 5)

Table of Contents

1 Introduction (Page No. - 13)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 17)
    2.1 Market Size Estimation
    2.2 Market Breakdown and Data Triangulation
    2.3 Assumptions for the Study

3 Executive Summary (Page No. - 24)

4 Topical Drug Delivery Market: Premium Insights (Page No. - 27)
    4.1 Global Market, By Route of Administration
    4.2 Global Market, By Product Type
    4.3 Global Market, By End User
    4.4 Geographic Snapshot of the Global Market

5 Market Overview (Page No. - 31)
    5.1 Introduction
    5.2 Market Dynamics
    5.3 Drivers
           5.3.1 High Prevalence of Skin Diseases
           5.3.2 Growing Preference for Topical Drug Delivery
           5.3.3 High Incidence of Burn Injuries
           5.3.4 Rising Incidence of Diabetes
           5.3.5 Rising Geriatric Population
    5.4 Restraints
           5.4.1 Negative Impact of Product Recalls
    5.5 Opportunities
           5.5.1 Delivery of Biologics Through the Transdermal Route
           5.5.2 Acquisition of Small Market Players
    5.6 Challenges
           5.6.1 Limited Therapeutic Areas of Topical Drug Delivery

6 Topical Drug Delivery Market, By Product Type (Page No. - 37)
    6.1 Introduction
           6.1.1 Formulations
                    6.1.1.1 Liquid Topical Formulations
                               6.1.1.1.1 Solutions
                               6.1.1.1.2 Suspensions
                    6.1.1.2 Semi-Solid Topical Formulations
                               6.1.1.2.1 Creams
                               6.1.1.2.2 Gels
                               6.1.1.2.3 Ointments
                               6.1.1.2.4 Pastes
                               6.1.1.2.5 Lotions
                    6.1.1.3 Solid Topical Formulations
                               6.1.1.3.1 Suppositories
                               6.1.1.3.2 Powders
           6.1.2 Devices (Transdermal Drug Delivery)
                    6.1.2.1 Transdermal Patches
                    6.1.2.2 Transdermal Gels

7 Topical Drug Delivery Market, By Route of Administration (Page No. - 52)
    7.1 Introduction
    7.2 Skin Drug Delivery
    7.3 Ophthalmic Drug Delivery
    7.4 Rectal Drug Delivery
    7.5 Vaginal Drug Delivery
    7.6 Nasal Drug Delivery

8 Topical Drug Delivery Market, By Facility of Use (Page No. - 61)
    8.1 Introduction
    8.2 Hospitals and Private Clinics
    8.3 Home Care Settings
    8.4 Other Facilities of Use

9 Topical Drug Delivery Market, By Region (Page No. - 66)
    9.1 Introduction
    9.2 North America
           9.2.1 U.S.
           9.2.2 Canada
    9.3 Europe
           9.3.1 Germany
           9.3.2 France
           9.3.3 U.K.
           9.3.4 Rest of Europe (RoE)
    9.4 Asia-Pacific (APAC)
           9.4.1 Japan
           9.4.2 China
           9.4.3 India
           9.4.4 Rest of Asia-Pacific
    9.5 Rest of the World (RoW)

10 Competitive Landscape (Page No. - 98)
     10.1 Overview
     10.2 Player Ranking
     10.3 Competitive Situation and Trends
             10.3.1 Product Launches and Approvals
             10.3.2 Acquisitions
             10.3.3 Agreements & Collaborations
             10.3.4 Expansions

11 Company Profiles (Page No. - 106)
(Overview, Products and Services, Financials, Strategy & Development)*
     11.1 Glaxosmithkline PLC
     11.2 Janssen Global Services, LLC. (A Subsidiary of Johnson & Johnson)
     11.3 Novartis AG
     11.4 Galderma S.A.
     11.5 Valeant Pharmaceuticals International, Inc.
     11.6 Bayer AG
     11.7 3M Drug Delivery Systems
     11.8 Crescita Therapeutics Inc.
     11.9 Medpharm
     11.10 Cipla

*Details on Overview, Products and Services, Financials, Strategy & Development Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. - 139)
     12.1 Insights From Industry Experts
     12.2 Discussion Guide
     12.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
     12.4 Other Developments
     12.5 Available Customizations
     12.6 RT: Real-Time Market Intelligence
     12.7 Related Reports
     12.8 Author Details


List of Tables (87 Tables)

Table 1 Topical Drug Delivery Market Size, By Product Type, 2014–2021 (USD Billion)
Table 2 Topical Drug Delivery Formulations Market Size, By Type, 2014–2021 (USD Billion)
Table 3 Topical Drug Delivery Formulations Market Size, By Region, 2014–2021 (USD Billion)
Table 4 Liquid Topical Formulations Market Size, By Dosage Form, 2014–2021 (USD Billion)
Table 5 Liquid Topical Formulations Market Size, By Region, 2014–2021 (USD Billion)
Table 6 Topical Solutions Market Size, By Region, 2014–2021 (USD Billion)
Table 7 Topical Suspensions Market Size, By Region, 2014–2021 (USD Billion)
Table 8 Semi-Solid Topical Formulations Market Size, By Dosage Form, 2014–2021 (USD Billion)
Table 9 Semi-Solid Topical Formulations Market Size, By Region, 2014–2021 (USD Billion)
Table 10 Topical Creams Market Size, By Region, 2014–2021 (USD Billion)
Table 11 Topical Gels Market Size, By Region, 2014–2021 (USD Billion)
Table 12 Topical Ointments Market Size, By Region, 2014–2021 (USD Billion)
Table 13 Topical Pastes Market Size, By Region, 2014–2021 (USD Billion)
Table 14 Topical Lotions Market Size, By Region, 2014–2021 (USD Billion)
Table 15 Solid Topical Formulations Market Size, By Dosage Form, 2014–2021 (USD Billion)
Table 16 Solid Topical Formulations Market Size, By Region, 2014–2021 (USD Billion)
Table 17 Topical Suppositories Market Size, By Region, 2014–2021 (USD Billion)
Table 18 Topical Powders Market Size, By Region, 2014–2021 (USD Billion)
Table 19 Transdermal Drug Delivery Devices Market Size, By Type, 2014–2021 (USD Billion)
Table 20 Transdermal Drug Delivery Devices Market Size, By Region, 2014–2021 (USD Billion)
Table 21 Transdermal Patches Market Size, By Region, 2014–2021 (USD Billion)
Table 22 Transdermal Gels Market Size, By Region, 2014–2021 (USD Billion)
Table 23 Topical Drug Delivery Market Size, By Route of Administration, 2014–2021 (USD Billion)
Table 24 Some Commercially Available Products
Table 25 Skin Drug Delivery Market Size, By Region, 2014–2021 (USD Billion)
Table 26 Commercially Available Products
Table 27 Ophthalmic Drug Delivery Market Size, By Region, 2014–2021 (USD Billion)
Table 28 Rectal Drug Delivery Market Size, By Region, 2014–2021 (USD Billion)
Table 29 Vaginal Drug Delivery Market Size, By Region, 2014–2021 (USD Billion)
Table 30 Commercially Available Products
Table 31 Nasal Drug Delivery Market Size, By Region, 2014–2021 (USD Billion)
Table 32 Global Topical Drug Delivery Market Size, By Facility of Use, 2014–2021 (USD Billion)
Table 33 Market Size for Hospitals and Private Clinics, By Region, 2014–2021 (USD Billion)
Table 34 Market Size for Home Care Settings, By Region, 2014–2021 (USD Billion)
Table 35 Market Size for Other Facilities of Use, By Region, 2014–2021 (USD Billion)
Table 36 Market Size, By Region, 2014-2021 (USD Billion)
Table 37 North America: Topical Drug Delivery Market Size, By Country, 2014-2021 (USD Billion)
Table 38 North America: Market Size, By Product Type, 2014–2021 (USD Billion)
Table 39 North America: Market Size, By Route of Administration, 2014–2021 (USD Billion)
Table 40 North America: Market Size, By Facility of Use, 2014–2021 (USD Billion)
Table 41 U.S.: Market Size, By Product Type, 2014–2021 (USD Billion)
Table 42 U.S.: Market Size, By Route of Administration, 2014–2021 (USD Billion)
Table 43 U.S.: Market Size, By Facility of Use, 2014–2021 (USD Billion)
Table 44 Canada: Topical Drug Delivery Market Size, By Product Type, 2014–2021 (USD Billion)
Table 45 Canada: Market Size, By Route of Administration, 2014–2021 (USD Billion)
Table 46 Canada: Market Size, By Facility of Use, 2014–2021 (USD Billion)
Table 47 Europe: Market Size, By Country, 2014–2021 (USD Billion)
Table 48 Europe: Market Size, By Product Type, 2014–2021 (USD Billion)
Table 49 Europe: Market Size, By Route of Administration, 2014–2021 (USD Billion)
Table 50 Europe: Market Size, By Facility of Use, 2014–2021 (USD Billion)
Table 51 Germany: Topical Drug Delivery Market Size, By Product Type, 2014–2021 (USD Billion)
Table 52 Germany: Market Size, By Route of Administration, 2014–2021 (USD Billion)
Table 53 Germany: Market Size, By Facility of Use, 2014–2021 (USD Billion)
Table 54 France: Market Size, By Product Type, 2014–2021 (USD Billion)
Table 55 France: Market Size, By Route of Administration, 2014–2021 (USD Billion)
Table 56 France: Market Size, By Facility of Use, 2014–2021 (USD Billion)
Table 57 U.K.: Topical Drug Delivery Market Size, By Product Type, 2014–2021 (USD Billion)
Table 58 U.K.: Market Size, By Route of Administration, 2014–2021 (USD Billion)
Table 59 U.K.: Market Size, By Facility of Use, 2014–2021 (USD Billion)
Table 60 RoE: Market Size, By Product Type, 2014–2021 (USD Billion)
Table 61 RoE: Market Size, By Route of Administration, 2014–2021 (USD Billion)
Table 62 RoE: Market Size, By Facility of Use, 2014–2021 (USD Billion)
Table 63 Asia-Pacific: Topical Drug Delivery Market Size, By Country, 2014–2021 (USD Billion)
Table 64 Asia-Pacific: Market Size, By Product Type, 2014–2021 (USD Billion)
Table 65 Asia-Pacific: Market Size, By Route of Administration, 2014–2021 (USD Billion)
Table 66 Asia-Pacific: Market Size, By Facility of Use, 2014–2021 (USD Billion)
Table 67 Japan.: Market Size, By Product Type, 2014–2021 (USD Billion)
Table 68 Japan: Market Size, By Route of Administration, 2014–2021 (USD Billion)
Table 69 Japan: Market Size, By Facility of Use, 2014–2021 (USD Billion)
Table 70 China: Topical Drug Delivery Market Size, By Product Type, 2014–2021 (USD Billion)
Table 71 China: Market Size, By Route of Administration, 2014–2021 (USD Billion)
Table 72 China: Market Size, By Facility of Use, 2014–2021 (USD Billion)
Table 73 India: Market Size, By Product Type, 2014–2021 (USD Billion)
Table 74 India: Market Size, By Route of Administration, 2014–2021 (USD Billion)
Table 75 India: Market Size, By Facility of Use, 2014–2021 (USD Billion)
Table 76 Rest of Asia-Pacific: Topical Drug Delivery Market Size, By Product Type, 2014–2021 (USD Billion)
Table 77 Rest of Asia-Pacific: Market Size, By Route of Administration, 2014–2021 (USD Billion)
Table 78 Rest of Asia-Pacific: Market Size, By Facility of Use, 2014–2021 (USD Billion)
Table 79 RoW: Market Size, By Product Type, 2014–2021 (USD Billion)
Table 80 RoW: Market Size, By Route of Administration, 2014–2021 (USD Billion)
Table 81 RoW: Market Size, By Facility of Use, 2014–2021 (USD Billion)
Table 82 Topical Drug Delivery Market, By Key Player, 2015
Table 83 Product Launches & Approvals, 2013–2016
Table 84 Acquisitions, 2013–2017
Table 85 Agreements & Collaborations, 2013–2016
Table 86 Expansions, 2013–2017
Table 87 Exchange Rate (Utilized for Conversion of Inr to USD)


List of Figures (41 Figures)

Figure 1 Research Design
Figure 2 Market Size Estimation: Bottom-Up Approach
Figure 3 Market Size Estimation: Top-Down Approach
Figure 4 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 5 Data Triangulation Methodology
Figure 6 Key Data From Secondary Sources
Figure 7 Key Data From Primary Sources
Figure 8 Formulations Segment is Expected to Dominate the Global Topical Drug Delivery Market, By Product (2016-2021)
Figure 9 Hospitals and Private Clinics Segment is Expected to Hold Largest Share of the Market, By Facility of Use (2016-2021)
Figure 10 Skin Drug Delivery Segment is Expected to Dominate the Topical Drug Delivery Market, By Route of Administration (2016-2021)
Figure 11 North America is Estimated to Hold the Largest Market Share in 2016, While Asia-Pacific is Expected to Witness Highest Growth (2016-2021)
Figure 12 Global Market Overview: Increasing Prevalence of Skin Diseases is Expected to Be the Key Driver of Market Growth
Figure 13 Formulations Segment is Expected to Dominate the Market, By Product
Figure 14 Skin is Estimated to Command the Largest Share of the Route of Administration Market in 2016
Figure 15 Semi-Solid Formulations Segment is Expected to Grow at the Highest CAGR in the Topical Drug Delivery Formulations Market (2016-2021)
Figure 16 Hospitals and Private Clinics Segment is Expected to Witness the Highest CAGR in the Forecast Period
Figure 17 Asia-Pacific is Expected to Grow at the Highest CAGR (2016-2021)
Figure 18 Topical Drug Delivery Market: Drivers, Restraints, Opportunities, and Challenges
Figure 19 Formulations are Estimated to Command the Larger Share of the Market in 2016
Figure 20 Transdermal Drug Delivery is Expected to Dominate the Market (2016-2021)
Figure 21 Asia-Pacific is Expected to Register the Highest CAGR in the Skin Drug Delivery Market (2016 - 2021)
Figure 22 Hospitals and Private Clinics Segment is Estimated to Command the Largest Share of the Global Market in 2016
Figure 23 Asia-Pacific Hospitals and Private Clinics Market is Expected to Witness Highest CAGR (2016 - 2021)
Figure 24 North America: Topical Drug Delivery Market Snapshot
Figure 25 Europe: Market Snapshot
Figure 26 Asia-Pacific: Market Snapshot
Figure 27 RoW: Market Snapshot
Figure 28 Key Developments in the Global Market, 2013–2017
Figure 29 Market Evolution Framework
Figure 30 Battle for Market Share: Product Launches and Approvals Accounted for the Largest Share of Strategies (2013-2016)
Figure 31 Geographic Revenue Mix of the Top Five Players in the Topical Drug Delivery Market, 2015
Figure 32 Glaxosmithkline PLC: Company Snapshot (2015)
Figure 33 Johnson & Johnson: Company Snapshot (2015)
Figure 34 Novartis AG: Company Snapshot (2015)
Figure 35 Nestlι S.A.: Company Snapshot (2015)
Figure 36 Valeant Pharmaceuticals International, Inc.: Company Snapshot (2015)
Figure 37 Bayer AG: Company Snapshot (2015)
Figure 38 Exchange Rate (Utilized for the Conversion of EUR to USD)
Figure 39 3M: Company Snapshot (2015)
Figure 40 Nuvo Research: Company Snapshot (2015)
Figure 41 Cipla: Company Snapshot (2015)

The topical drug delivery market is expected to reach USD 125.88 Billion by 2021 from USD 92.40 Billion in 2016 at a CAGR of 6.4% during the forecast period. Major factors driving the growth of this market are the high incidence of burn injuries, rising geriatric population, and increasing incidence of diabetes.

The market is segmented based on product type, route of administration, facility of use, and regions. On the basis of product type, the market is segmented into formulations and devices (transdermal drug delivery). Transdermal drug delivery is expected to offer lucrative growth opportunities and represents a new revenue pocket for market players. This is because transdermal drug delivery offers enhanced therapeutic efficiency and helps maintain a steady plasma level of the drug.

On the basis of route of administration, the market is segmented into skin, ophthalmic, rectal, vaginal, and nasal routes. Considering the high incidence of skin diseases, high demand for self-administration, and the increasing number of product approvals for skin-related drug delivery systems, the market for topical drugs administered through the skin is expected to register the highest CAGR during the forecast period.

Based on facility of use, the topical drug delivery market is categorized into hospitals and private clinics, health care settings, and other facilities of use such as research institutes and diagnostic centers. The hospitals and private clinics segment is expected to be the major end-user in the market. This large share of this segment can is mainly attributed to the increasing incidence of skin diseases, the subsequent increase in the demand for topical products for the treatment of these diseases, increase in funding, and infrastructural development in hospitals.

Topical Drug Delivery Market

Based on region, North America dominates the market, followed by Europe. However, the market in the Asia-Pacific is expected to witness the highest growth during the forecast period. The high growth in the Asia-Pacific market can be attributed to the rising geriatric population, increasing healthcare expenditure, rising disposable income, and growing focus of global pharmaceutical companies on the markets in emerging APAC countries.

Key players operating in the global topical drug delivery market are Galderma S.A. (Switzerland), GlaxoSmithKline plc. (U.K.), Valeant Pharmaceuticals International, Inc. (Canada), Crescita Therapeutics Inc. (Canada), Medpharm (U.K.), 3M (U.S.), Bayer AG (Germany), Novartis AG (Switzerland), Janssen Global Services, LLC (U.S.), and Cipla (India).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit https://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Medical Devices Markets on KnowledgeStore
Request Demo